Physician profile

Jacqueline E Gabay

Ophthalmology · Elmwood Park, NJ

NPI 1245310531

$8,143.16

in general payments reported to CMS, 2019-2025

31 companies · $1,971 in 2025

The $1,971 reported for 2025 was more than what 88% of Ophthalmology providers received nationally (typical 2025 total: $384).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$4,725.58
Education$34.74

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Glaukos Corporation $1,294.85 2020-2025 Idose, Idosetr
Abbvie INC. $1,049.57 2022-2025
Allergan, INC. $995.65 2019-2022
Sun Pharmaceutical Industries INC. $795.29 2019-2025 Cequa
Alcon Vision LLC $555.37 2019-2025 Hydrus Microstent, Clareon, Rocklatan
Bausch & Lomb Americas INC. $390.66 2023-2025 Vyzulta, Envista Mx60 Iol, Miebo
Harrow Eye, LLC $341.94 2024-2025 Vevye
Sight Sciences, INC. $311.75 2019-2025 Omni Surgical System, Sion Surgical Instrument
New World Medical,INC. $265.47 2021-2025 Clearpath, Via360, Streamline
Novartis Pharmaceuticals Corporation $232.14 2019-2023
Emergent Biosolutions INC. $212.02 2019
Johnson & Johnson Surgical Vision, INC. $184.80 2019-2024 Tecnis Iol, Tecnis Iol
Oyster Point Pharma, INC. $182.97 2022-2025 Tyrvaya
Biotissue Holdings INC. $180.07 2021-2024
Tarsus Pharmaceuticals, INC. $144.67 2024-2025 Xdemvy
Show all 31 companies
CompanyGeneral paymentsYearsTop products
Rxsight INC $139.29 2025 Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens
Glaxosmithkline, LLC. $120.69 2021
Shire North American Group INC $101.95 2019
Dompe US, INC. $101.95 2022-2025 Oxervate
Eyevance Pharmaceuticals LLC $90.50 2020-2022
Aerie Pharmaceuticals, INC. $87.01 2019-2021
Ocular Therapeutix, INC. $78.54 2021-2024 Dextenza
Mallinckrodt Hospital Products INC. $62.06 2020-2025 Acthar
Bausch & Lomb, A Division of Bausch Health US, LLC $53.45 2019-2021
Notal Vision, INC. $47.72 2021
Amgen INC. $27.69 2024 Tepezza
Alimera Sciences, INC. $21.11 2024 Iluvien, Yutiq
Ivantis, INC $20.45 2019
Apellis Pharmaceuticals, INC. $20.04 2024 Syfovre
Travere Therapeutics, INC. $17.05 2021
Rayner Intraocular Lenses Limited $16.44 2025 Omidria

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Jacqueline E Gabay

$8,143.16

in general payments reported 2019-2025

Years
2019-2025
Top company
Glaukos Corporation
Context
The $1,971 reported for 2025 was more than what 88% of Ophthalmology providers received nationally (typical 2025 total: $384).

https://glasscript.com/doctor/146899/jacqueline-e-gabay

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.